Literature DB >> 29285684

Socioeconomic Disparities and Metabolic Risk in Veterans with Serious Mental Illness.

Stanley N Caroff1,2, Shirley H Leong3, Daisy Ng-Mak4, E Cabrina Campbell3, Rosalind M Berkowitz3, Krithika Rajagopalan4, Chien-Chia Chuang5, Antony Loebel6.   

Abstract

Socioeconomic disparities were assessed in predicting metabolic risk among veterans with serious mental illness. Veterans with schizophrenia, schizoaffective, or bipolar disorders were identified in VISN 4 facilities from 10/1/2010 to 9/30/2012. Differences between patients with and without metabolic syndrome were compared using t-tests, Chi square tests and multivariate logistic regressions. Among 10,132 veterans with mental illness, 48.8% had metabolic syndrome. Multivariate logistic regression analysis confirmed that patients with metabolic syndrome were significantly more likely to be older, male, African-American, married, and receiving disability pensions but less likely to be homeless. They were more likely to receive antipsychotics, antidepressants, or anticonvulsants. Bivariate cross-sectional analysis revealed that patients with metabolic syndrome had higher rates of coronary artery disease, cerebrovascular disease, and mortality, and that metabolic syndrome was more often associated with emergency visits and psychiatric or medical hospitalizations. Demographics, socioeconomic status and medications are independent predictors of metabolic syndrome and should be considered in broader screening of risk factors in order to provide preventive interventions for metabolic syndrome.

Entities:  

Keywords:  Antidepressants; Antipsychotics; Bipolar disorder; Diabetes; Metabolic syndrome; Schizophrenia

Mesh:

Substances:

Year:  2017        PMID: 29285684     DOI: 10.1007/s10597-017-0215-7

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  40 in total

1.  Geographic variation in health care and the problem of measuring racial disparities.

Authors:  Katherine Baicker; Amitabh Chandra; Jonathan S Skinner
Journal:  Perspect Biol Med       Date:  2005       Impact factor: 1.416

2.  Does antipsychotic polypharmacy increase the risk for metabolic syndrome?

Authors:  Christoph U Correll; Anne M Frederickson; John M Kane; Peter Manu
Journal:  Schizophr Res       Date:  2006-10-27       Impact factor: 4.939

3.  A ten-year perspective of mortality risk among mentally ill patients in sheltered care.

Authors:  S P Segal; P L Kotler
Journal:  Hosp Community Psychiatry       Date:  1991-07

4.  The association between income and distress, mental disorders, and suicidal ideation and attempts: findings from the Collaborative Psychiatric Epidemiology Surveys.

Authors:  Katherine A McMillan; Murray W Enns; Gordon J G Asmundson; Jitender Sareen
Journal:  J Clin Psychiatry       Date:  2010-04-06       Impact factor: 4.384

5.  Antipsychotic treatment and mortality in schizophrenia.

Authors:  Minna Torniainen; Ellenor Mittendorfer-Rutz; Antti Tanskanen; Charlotte Björkenstam; Jaana Suvisaari; Kristina Alexanderson; Jari Tiihonen
Journal:  Schizophr Bull       Date:  2014-11-24       Impact factor: 9.306

Review 6.  Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis.

Authors:  Elizabeth Reisinger Walker; Robin E McGee; Benjamin G Druss
Journal:  JAMA Psychiatry       Date:  2015-04       Impact factor: 21.596

7.  Association of psychiatric illness and all-cause mortality in the National Department of Veterans Affairs Health Care System.

Authors:  Lydia A Chwastiak; Robert A Rosenheck; Rani Desai; Lewis E Kazis
Journal:  Psychosom Med       Date:  2010-07-16       Impact factor: 4.312

8.  Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilization.

Authors:  Laurel A Copeland; John E Zeber; Chen-Pin Wang; Michael L Parchman; Valerie A Lawrence; Marcia Valenstein; Alexander L Miller
Journal:  BMC Health Serv Res       Date:  2009-07-26       Impact factor: 2.655

9.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

10.  The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia.

Authors:  Jonathan M Meyer; Lisa C Rosenblatt; Edward Kim; Ross A Baker; Richard Whitehead
Journal:  J Clin Psychiatry       Date:  2008-12-16       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.